Abstract
The innate immunity protein lactoferrin (Lf) since its discovery from bovine milk in 1939, and then from human and other mammals’ milk has been studied extensively for its structure, function, and multifunctional properties. Lf is an iron-binding glycoprotein present in breast milk (colostral, mature, and whey fraction of milk), and in mammalian secretions such as synovial fluid, seminal plasma, tear fluid, and saliva. Also known as an innate antibiotic as it plays role in iron hemostasis and protection against microbial infections. It has antiinflammatory, immunomodulatory, and immunoregulatory properties and protects against growth and advancement of tumors.
Worldwide data from animal feeding studies and clinical trials support bovine milk–derived Lf (bLf) and it is proven safety profile, chemopreventive, and anticarcinogenic activities. It was found that bLf may inhibit colon, lung, esophagus, and bladder cancer in animal models. It reduces the side effects of chemotherapy by increasing the number of white and red blood cells to normal levels. Lf also has antioxidant, antiviral, and antimicrobial effects and has the capability to bind to iron, and this explains its ability to have antibacterial activity. It was proven that Lf receptors are located on macrophages and leukocytes, bacteria and platelets, and also in the gastrointestinal tract. It could be used in clinical testing due to its effect on skeletal muscle so it may help in treatment of osteoporosis. In this chapter, we describe the preclinical and clinical potential of cancer targeting properties of lactoferrin, especially bLf including its development as a multimodular theranostic.
https://www.sciencedirect.com/science/article/pii/B9780128196663000080
Bibliography:
- Ali O.M. et al. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Colloids Surf B. Biointerfaces. 2020 Apr; vol.188:110824.
- Elzoghby Ahmed O.et al. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand
- Groves Merton L. The Isolation of a Red Protein from Milk2. J. Am. Chem. Soc. 1960, 82, 13, 3345–3350
- Satué-Gracia M. T. et al. Lactoferrin in infant formulas: effect on oxidation. J. Agric. Food Chem. 2000 Oct;48(10):4984-90.
- Superti Fabiana. Lactoferrin from Bovine Milk: A Protective Companion for Life. Nutrients 2020, 12(9), 2562
- Takayama Y. & Takezawa T. Lactoferrin promotes collagen gel contractile activity of fibroblasts mediated by lipoprotein receptors. Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire, 01 Jun 2006, 84(3):268-274
- Donovan Sharon M.; The Role of Lactoferrin in Gastrointestinal and Immune Development and Function: A Preclinical Perspective. The Journal of Pediatrics VOLUME 173, SUPPLEMENT , S16-S28, JUNE 01, 2016
- Doyle Lex W. & Jeanie L. Y. Cheong. Does bovine lactoferrin prevent late-onset neonatal sepsis? The Lancet VOLUME 393, ISSUE 10170, P382-384, FEBRUARY 02, 2019
- ELFIN Trial Investigators Group; Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial. Lancet VOLUME 393, ISSUE 10170, P423-433, FEBRUARY 02, 2019
- Kaur Gurpreet & Geeta Gathwala. Efficacy of Bovine Lactoferrin Supplementation in Preventing Late-onset Sepsis in low Birth Weight Neonates: A Randomized Placebo-Controlled Clinical Trial. Journal of Tropical Pediatrics, Volume 61, Issue 5, October 2015, Pages 370–376
- Legrand Dominique. Overview of Lactoferrin as a Natural Immune Modulator. The Journal of Pediatrics VOLUME 173, SUPPLEMENT , S10-S15, JUNE 01, 2016
- Pammi Mohan & Gautham Suresh; Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev.2017 Jun 28;6(6):CD007137.
- Trend Stephanie et al.; Levels of innate immune factors in preterm and term mothers’ breast milk during the 1st month postpartum. British Journal of Nutrition Volume 115 supplement 7.
- Awadasseid A. et al.; Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci. 2020 Apr 6;16(11):1846-1860. doi: 10.7150/ijbs.45018. eCollection 2020.
- Binte Aziz Asma; Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? Biosafety and Health, 2020
- Blaess M. et al.; COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Int J Mol Sci. 2020 Jul 13;21(14):4953. doi: 10.3390/ijms21144953.
- Campione Elena et al.; Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation; Int. J. Mol. Sci. 2020, 21(14), 4903
- Chang Raymond, Tzi Bun Ng, Wei-ZenSun; Lactoferrin as potential preventative and adjunct treatment for COVID-19; International Journal of Antimicrobial Agents Volume 56, Issue 3, September 2020, 106118
- Church Dawson et al., App-Based Delivery of Clinical Emotional Freedom Techniques: Cross-Sectional Study of App User Self-Ratings; JMIR Mhealth Uhealth, 2020
- Deshmukh V, et al.; COVID-19: a conundrum to decipher. Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
- Drago-Serrano et al.; Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections; Int J Mol Sci, 2017
- Fernández-Lázaro Diego et al.; Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy? Int J Environ Res Public Health
- Jawhara et al.; Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Int J Mol Sci, 2020
- Mirabelli Carmen et al.; Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19; BioRxiv. Preprint. NaN NaN [revised 2020 Sep 28].
Original articol
- Root‐Bernstein Robert Age and Location in Severity of COVID‐19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
https://www.youtube.com/watch?v=GODBYRbPL00&feature=youtu.be
Original article
Original article
- Universidad Peruana Cayetano Heredia; Lactoferrin for Prevention of COVID-19 in Health Care Workers
- Università Tor Vergata - Una risposta contro il Covid-19: la glicoproteina lattoferrina, una componente dell’immunità innata
- Zhai Xiaofeng et al; Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.; J Virol. 2020 Jul 16;94(15):e00831-20. doi: 10.1128/J. Vi.00831-20. Print 2020 Jul 16.
- Zhang Wan-Ying et al.: Molecular mechanism prediction analysis of compound Kushen injection in the treatment of COVID-19 based on network pharmacology and molecular docking. Traditional Medicine Research 2020, 5 (5): 413-424. doi: 10.12032/TMR20200518180
- Zhang Wan-Ying et al.; Treating COVID-19 by traditional Chinese medicine: a charming strategy?Traditional Medicine Research 2020, Vol. 5 Issue (4): 178-181
